Mitre Medical

Mitre_Medical_LOGO_HI-REZ

Mitre Medical Corp. Announces Presentation and Participation at the MedTech Emerging Growth Companies 2020 Virtual Roadshow

October 12, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre” or “company”) is an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat functional mitral valve regurgitation (FMR) and remodel the left ventricle (LV).  Mitre is pleased to announce that the company will be presenting at … Read more

Mitre Medical Corp. Accepted into the Harmonization by Doing (HBD) Program

Advances Regulatory Strategy for the Mitral Touch in US and Japan October 9, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre” or “company”) is an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat functional mitral valve regurgitation (FMR) and remodel the left ventricle (LV).  The … Read more

Mitre Medical Corp. Strengthens Global Marketing Team with the Appointment of MedMarket Access, LLC

September 10, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre” or “company”) is an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat functional mitral valve regurgitation (FMR) and remodel the left ventricle (LV).  Mitre has appointed MedMarket Access, LLC (“MedMarket Access”) to support the company’s … Read more

Mitre Medical Corp. Retains Zimmons International Communications, Inc. for Investor Relations Activities

August 27, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre Medical” or “company”), an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat mitral valve regurgitation (MR) and remodel the left ventricle (LV) in patients with moderate to severe MR, has retained Zimmons International Communications, Inc. … Read more

Mitre Medical Receives FDA Approval For the ENRAPT-US Early Feasibility Study

The Mitral Touch Empowers Surgeons to Treat Functional MR on a Beating Heart Mitre Medical is pleased to announce concurrent to the PCR-London Valves Conference that the FDA has determined Mitre Medical Corp. has provided sufficient data to support initiation of a human clinical study to evaluate the safety and performance of the Mitral Touch … Read more

Structural Heart Treatment Meets Structural Heart Imaging: Mitre Medical Announces Partnership with Laralab

New AI-based CT Imaging Helps Screen and Assess Patients for the Mitral Touch Epicardial Clip Mitre Medical Corp. and Laralab UG have partnered to provide surgeons with the most advanced 3D epicardial models ever made prior to surgery. This software has also provided the assessment of the Mitral Touch’s performance in heart failure patients in … Read more

Minimally Invasive Delivery of the Mitral Touch and 1-Year Follow-Up of the ENRAPT-MR Study will be Presented at EACTS 2019 Techno College

The Mitral Touch Represents a Breakthrough in the Surgical Treatment of Heart Failure The Mitral Touch is an epicardial clip designed to reduce mitral regurgitation and provide subvalvular support of the left ventricle for functional mitral regurgitation (FMR) patients. The ENRAPT-MR study investigated the safety and performance of the Mitral Touch during concomitant treatment of … Read more

Edwards Announces 6-Month Pascal Results – Eyes MitraClip Market

PARIS, May 22, 2019 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regulatory milestones for its Edwards PASCAL transcatheter valve repair system. Today at the EuroPCR annual course in Paris, new 6-month data from the CLASP study of the PASCAL … Read more